Cuorips (TSE:4894) Accounts Payable: 円242.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4894 Cuorips Inc TSE:4894
67 GF Score
Price 円4,235.00
GF Value 円29,062.84
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Cuorips Accounts Payable?

Cuorips TSE:4894 +2.54% 67 Accounts Payable is 円242.2 Mil as of Mar. 2026. GuruFocus rates TSE:4894 with a GF Score™ of 67/100 and a GF Value™ of 円29,062.84 (Possible Value Trap). The stock has 2 warning signs investors should review.

Cuorips's Accounts Payable for the quarter that ended in Mar. 2026 was 円242.2 Mil.

Cuorips's quarterly Accounts Payable declined from Mar. 2025 (円132.2 Mil) to Sep. 2025 (円54.9 Mil) but then increased from Sep. 2025 (円54.9 Mil) to Mar. 2026 (円242.2 Mil).

Cuorips's annual Accounts Payable increased from Mar. 2024 (円91.7 Mil) to Mar. 2025 (円132.2 Mil) and increased from Mar. 2025 (円132.2 Mil) to Mar. 2026 (円242.2 Mil).

Cuorips Accounts Payable Historical Data

* Premium members only.

The historical data trend for Cuorips's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cuorips Accounts Payable Chart

Cuorips Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial 43.64 55.25 91.67 132.22 242.23

Cuorips Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only 91.67 92.22 132.22 54.86 242.23
TSE:4894
67GF Score
Cuorips Inc TSE:4894
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cuorips Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of 円242.2 Mil mean?
Cuorips (TSE:4894) has a Accounts Payable of 円242.2 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cuorips and its competitors.
Is Cuorips' Accounts Payable too high?
Cuorips' current Accounts Payable is 円242.2 Mil. Overall, Cuorips has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cuorips' Accounts Payable compare to VRTX and REGN?
Cuorips' Accounts Payable of 円242.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cuorips and its competitors. Cuorips's current Accounts Payable is 円242.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuorips stock overvalued right now?
Based on GuruFocus' analysis, Cuorips (TSE:4894) is currently considered Possible Value Trap. The stock's GF Value™ is 円29,062.84, compared to a current price of 円4,235.00 — trading 85.4% below its estimated fair value. The current Accounts Payable is 円242.2 Mil. Cuorips' overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Cuorips (TSE:4894), the current Accounts Payable is 円242.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cuorips (TSE:4894) Overvalued in 2026?

Based on GuruFocus' analysis, Cuorips stock appears to be undervalued. The current stock price of 円4,235.00 is trading 85.4% below its estimated GF Value™ of 円29,062.84. GuruFocus considers Cuorips to be Possible Value Trap.

Key valuation signals for TSE:4894:

  • Accounts Payable: 円242.2 Mil
  • GF Value™: 円29,062.84 vs. price of 円4,235.00 (85.4% below fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the TSE:4894 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cuorips Business Description

Address 3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023
Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.
67GF Score

Get the complete analysis for TSE:4894

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,235.00
Price
円29,062.84
GF Value